{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:01:50Z","timestamp":1780761710116,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1245\/s10434-025-18235-3","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:24:22Z","timestamp":1775046262000},"page":"6063-6075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term Outcomes in Gallbladder Cancer Patients Treated with Curative-Intent Resection: Adjuvant Chemotherapy Versus Observation in a Multicenter Propensity Score-Matched Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Lin-Yi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Ran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Su","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Yu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"22","key":"18235_CR1","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017;23(22):3978\u201398.","journal-title":"World J Gastroenterol."},{"key":"18235_CR2","doi-asserted-by":"publisher","first-page":"1183619","DOI":"10.3389\/fphar.2023.1183619","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Yuan K, Yang Y, et al. Gallbladder cancer: current and future treatment options. Front Pharmacol. 2023;14:1183619.","journal-title":"Front Pharmacol."},{"issue":"1","key":"18235_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8(1):69.","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"18235_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.678","volume":"12","author":"B Yuan","year":"2022","unstructured":"Yuan B, Zhao X, Wang X, et al. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening. Clin Transl Med. 2022;12(1):e678.","journal-title":"Clin Transl Med."},{"issue":"1","key":"18235_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1245\/s10434-020-09108-y","volume":"28","author":"K Sahara","year":"2021","unstructured":"Sahara K, Tsilimigras DI, Kikuchi Y, et al. Defining and predicting early recurrence after resection for gallbladder cancer. Ann Surg Oncol. 2021;28(1):417\u201325.","journal-title":"Ann Surg Oncol."},{"issue":"14","key":"18235_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med."},{"issue":"5","key":"18235_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663\u201373.","journal-title":"Lancet Oncol."},{"issue":"10372","key":"18235_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","volume":"401","author":"K Nakachi","year":"2023","unstructured":"Nakachi K, Ikeda M, Konishi M, et al. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2023;401(10372):195\u2013203.","journal-title":"Lancet."},{"issue":"10272","key":"18235_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344.","journal-title":"Lancet."},{"issue":"9","key":"18235_CR10","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1097\/JS9.0000000000000510","volume":"109","author":"ZP Liu","year":"2023","unstructured":"Liu ZP, Guo W, Yin DL, et al. Textbook outcomes in liver surgery for gallbladder cancer patients treated with curative-intent resection: a multicenter observational study. Int J Surg. 2023;109(9):2751\u201361.","journal-title":"Int J Surg."},{"issue":"3","key":"18235_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/cancers13030547","volume":"13","author":"D Giannis","year":"2021","unstructured":"Giannis D, Cerullo M, Moris D, et al. Validation of the 8th edition American Joint Commission on Cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors. Cancers. 2021;13(3):547.","journal-title":"Cancers."},{"issue":"3","key":"18235_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivariate Behav Res."},{"key":"18235_CR13","unstructured":"Wang X, Liu L, Liu ZP, et al. Machine learning model to predict early recurrence in patients with perihilar cholangiocarcinoma planned treatment with curative resection: a multicenter study. J Gastrointest Surg. 2024:S1091-1255X(24)00642-00645 [pii]."},{"key":"18235_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.849053","volume":"12","author":"ZP Liu","year":"2022","unstructured":"Liu ZP, Chen WY, Wang ZR, et al. Development and validation of a prognostic model to predict recurrence-free survival after curative resection for perihilar cholangiocarcinoma: a multicenter study. Front Oncol. 2022;12:849053.","journal-title":"Front Oncol."},{"key":"18235_CR15","doi-asserted-by":"publisher","first-page":"1059581","DOI":"10.3389\/fonc.2022.1059581","volume":"12","author":"ZP Liu","year":"2022","unstructured":"Liu ZP, Cheng ZJ, Dai HS, et al. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection: a multicentre propensity score matching study. Front Oncol. 2022;12:1059581.","journal-title":"Front Oncol."},{"issue":"7","key":"18235_CR16","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1245\/s10434-022-11721-y","volume":"29","author":"ZP Liu","year":"2022","unstructured":"Liu ZP, Yao LQ, Diao YK, et al. Association of preoperative body mass index with surgical textbook outcomes following hepatectomy for hepatocellular carcinoma: a multicenter study of 1206 patients. Ann Surg Oncol. 2022;29(7):4278\u201386.","journal-title":"Ann Surg Oncol."},{"key":"18235_CR17","doi-asserted-by":"publisher","first-page":"1104810","DOI":"10.3389\/fonc.2022.1104810","volume":"12","author":"MY Ge","year":"2022","unstructured":"Ge MY, Liu ZP, Pan Y, et al. Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: a multicenter study of 333 patients. Front Oncol. 2022;12:1104810.","journal-title":"Front Oncol."},{"issue":"6","key":"18235_CR18","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1097\/JS9.0000000000001379","volume":"110","author":"XL Li","year":"2024","unstructured":"Li XL, Liu ZP, Su XX, et al. Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19\u20139 to total bilirubin (CA19-9\/TB): a multicenter retrospective cohort study. Int J Surg. 2024;110(6):3580\u201390.","journal-title":"Int J Surg."},{"issue":"9","key":"18235_CR19","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3748\/wjg.v28.i9.948","volume":"28","author":"ZP Liu","year":"2022","unstructured":"Liu ZP, Chen WY, Zhang YQ, et al. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma. World J Gastroenterol. 2022;28(9):948\u201360.","journal-title":"World J Gastroenterol."},{"issue":"10","key":"18235_CR20","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.21873\/anticanres.15342","volume":"41","author":"S Mori","year":"2021","unstructured":"Mori S, Aoki T, Shiraki T, et al. Efficacy and feasibility of adjuvant gemcitabine plus cisplatin chemotherapy after major hepatectomy for biliary tract cancer. Anticancer Res. 2021;41(10):5231\u201340.","journal-title":"Anticancer Res."},{"issue":"6","key":"18235_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/00031348241227188","volume":"90","author":"M Yoshida","year":"2024","unstructured":"Yoshida M, Yanagimoto H, Tsugawa D, et al. Efficacy of S-1 adjuvant chemotherapy for resected biliary tract cancer: a retrospective propensity-matched analysis. Am Surg. 2024;90(6):1279\u201389.","journal-title":"Am Surg."},{"issue":"3","key":"18235_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10147-013-0578-x","volume":"19","author":"K Yamanaka","year":"2014","unstructured":"Yamanaka K, Hatano E, Kanai M, et al. A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer. Int J Clin Oncol. 2014;19(3):485\u20139.","journal-title":"Int J Clin Oncol."},{"issue":"9935","key":"18235_CR23","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379.","journal-title":"Lancet."},{"issue":"1","key":"18235_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11864-023-01153-5","volume":"25","author":"W Margaret","year":"2024","unstructured":"Margaret W, Rajiv A, Laura G, Natalie L, Chandrasekhar P, Thatcher H. Current standards, multidisciplinary approaches, and future directions in the management of extrahepatic cholangiocarcinoma. Curr Treat Options Oncol. 2024;25(1):127\u201360.","journal-title":"Curr Treat Options Oncol."},{"issue":"1","key":"18235_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-013013","volume":"15","author":"FP Lemaigre","year":"2020","unstructured":"Lemaigre FP. Development of the intrahepatic and extrahepatic biliary tract: a framework for understanding congenital diseases. Ann Rev Pathol Mech Dis. 2020;15(1):1\u201322.","journal-title":"Ann Rev Pathol Mech Dis."},{"issue":"8","key":"18235_CR26","volume":"14","author":"SA Halaseh","year":"2022","unstructured":"Halaseh SA, Halaseh S, Shakman R. A review of the etiology and epidemiology of gallbladder cancer: what you need to know. Cureus. 2022;14(8):e28260.","journal-title":"Cureus."},{"issue":"6","key":"18235_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"SI Ilyas","year":"2013","unstructured":"Ilyas SI, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215\u201329.","journal-title":"Gastroenterology."},{"key":"18235_CR28","doi-asserted-by":"publisher","first-page":"930611","DOI":"10.3389\/fonc.2022.930611","volume":"12","author":"Y Haipeng","year":"2022","unstructured":"Haipeng Y, Yan X, Wei G, et al. Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer. Front Oncol. 2022;12:930611.","journal-title":"Front Oncol."},{"key":"18235_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103328","volume":"163","author":"AA Azizi","year":"2021","unstructured":"Azizi AA, Lamarca A, McNamara MG, Valle JW. Chemotherapy for advanced gallbladder cancer (GBC): a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2021;163:103328.","journal-title":"Crit Rev Oncol Hematol."},{"issue":"8","key":"18235_CR30","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/jamaoncol.2024.1944","volume":"10","author":"V Ostwal","year":"2024","unstructured":"Ostwal V, Patkar S, Engineer R, et al. Adjuvant gemcitabine plus cisplatin and chemoradiation in patients with gallbladder cancer: a randomized clinical trial. JAMA Oncol. 2024;10(8):1116\u201320.","journal-title":"JAMA Oncol."},{"issue":"4","key":"18235_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108047","volume":"50","author":"Y Wang","year":"2024","unstructured":"Wang Y, Kong Y, Yang Q, Zhong C, Zhou D, Wang W. Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis. Eur J Surg Oncol. 2024;50(4):108047.","journal-title":"Eur J Surg Oncol."},{"issue":"6","key":"18235_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJMp1604635","volume":"375","author":"LE Bothwell","year":"2016","unstructured":"Bothwell LE, Podolsky SH. The emergence of the randomized, controlled trial. N Engl J Med. 2016;375(6):501\u20134.","journal-title":"N Engl J Med."},{"issue":"3","key":"18235_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","volume":"69","author":"MC Elze","year":"2017","unstructured":"Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017;69(3):345\u201357.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"18235_CR34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bja.2023.06.054","volume":"131","author":"BY Andrew","year":"2023","unstructured":"Andrew BY, Alan Brookhart M, Pearse R, Raghunathan K, Krishnamoorthy V. Propensity score methods in observational research: brief review and guide for authors. Br J Anaesth. 2023;131(5):805\u20139.","journal-title":"Br J Anaesth."},{"issue":"4","key":"18235_CR35","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1097\/SLA.0000000000005154","volume":"277","author":"LE de Savornin","year":"2023","unstructured":"de Savornin LE, de Bitter T, Hannink G, et al. Development and external validation of a model to predict overall survival in patients with resected gallbladder cancer. Ann Surg. 2023;277(4):e856\u201363.","journal-title":"Ann Surg."},{"issue":"1","key":"18235_CR36","doi-asserted-by":"publisher","first-page":"11770","DOI":"10.1038\/s41598-019-48099-z","volume":"9","author":"TH Kim","year":"2019","unstructured":"Kim TH, Woo SM, Lee WJ, et al. Benefit of adjuvant chemoradiotherapy in resected gallbladder carcinoma. Sci Rep. 2019;9(1):11770.","journal-title":"Sci Rep."},{"key":"18235_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101936","volume":"84","author":"A Lamarca","year":"2020","unstructured":"Lamarca A, Edeline J, McNamara MG, et al. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treat Rev. 2020;84:101936.","journal-title":"Cancer Treat Rev."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18235-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:47Z","timestamp":1780761107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18235-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["18235"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18235-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}